We provide you with 20 years of free, institutional-grade data for KYMR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of KYMR. Explore the full financial landscape of KYMR stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$339,371,374
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Mainolfi Nello | Sale | -50,000 | $119 | $5,950,000 | 2026-07-07 |
| Mainolfi Nello | Derivatives Exercise | 50,000 | 2026-07-07 | ||
| Jacobs Bruce N. | Sale | -77,109 | $110.54 | $8,523,606 | 2026-07-02 |
| Jacobs Bruce N. | Derivatives Exercise | 61,378 | 2026-07-02 | ||
| Goodman Noah | Sale | -3,389 | $114.29 | $387,329 | 2026-07-02 |
| Mainolfi Nello | Sale | -80,000 | $112.8 | $9,024,368 | 2026-07-02 |
| Mainolfi Nello | Derivatives Exercise | 80,000 | 2026-07-02 | ||
| Booth Bruce | Sale | -9,411 | $105.78 | $995,496 | 2026-07-02 |
| Booth Bruce | Sale | -67,239 | $105.78 | $7,112,541 | 2026-07-02 |
| Booth Bruce | Sale | -67,924 | $107.57 | $7,306,585 | 2026-06-30 |
| Booth Bruce | Sale | -476,604 | $107.57 | $51,268,292 | 2026-06-30 |
| BVF PARTNERS L P/IL | Sale | -51,858 | $106.5 | $5,522,877 | 2026-06-26 |
| BVF PARTNERS L P/IL | Sale | -1,578,800 | $106.5 | $168,142,200 | 2026-06-26 |
| Booth Bruce | Sale | -84,044 | $99.98 | $8,402,719 | 2026-06-25 |
| Booth Bruce | Sale | -600,405 | $99.98 | $60,028,492 | 2026-06-25 |
| Goodman Noah | Sale | -5,000 | $109 | $545,000 | 2026-06-25 |
| Goodman Noah | Derivatives Exercise | 5,000 | 2026-06-25 | ||
| Jacobs Bruce N. | Derivatives Exercise | 12,653 | 2026-06-03 | ||
| Chadwick Jeremy G | Sale | -17,184 | $78.36 | $1,346,485 | 2026-05-27 |
| Jacobs Bruce N. | Derivatives Exercise | 15,000 | 2026-05-19 | ||
| Esposito Pamela | Derivatives Exercise | 1,000 | 2026-05-19 | ||
| Ridloff Elena | Sale | -3,000 | $87 | $261,000 | 2026-05-11 |
| Ridloff Elena | Derivatives Exercise | 3,000 | 2026-05-11 | ||
| Mainolfi Nello | Sale | -30,000 | $80.74 | $2,422,200 | 2026-04-29 |
| Mainolfi Nello | Derivatives Exercise | 30,000 | 2026-04-29 | ||
| Chadwick Jeremy G | Sale | -300 | $90 | $27,000 | 2026-04-24 |
| Chadwick Jeremy G | Derivatives Exercise | 300 | 2026-04-24 | ||
| Booth Bruce | Sale | -12 | $90.08 | $1,081 | 2026-04-24 |
| Booth Bruce | Sale | -88 | $90.08 | $7,927 | 2026-04-24 |
| Booth Bruce | Sale | -5,900 | $89.96 | $530,764 | 2026-04-24 |
| Booth Bruce | Derivatives Exercise | 5,900 | 2026-04-24 | ||
| Chadwick Jeremy G | Sale | -6,551 | $90 | $589,600 | 2026-04-16 |
| Chadwick Jeremy G | Derivatives Exercise | 6,551 | 2026-04-16 | ||
| Booth Bruce | Sale | -385 | $90.1 | $34,689 | 2026-04-16 |
| Booth Bruce | Sale | -2,750 | $90.1 | $247,775 | 2026-04-16 |
| Booth Bruce | Sale | -6,359 | $89.97 | $572,119 | 2026-04-16 |
| Booth Bruce | Derivatives Exercise | 6,359 | 2026-04-16 | ||
| Goodman Noah | Sale | -1,347 | $90 | $121,230 | 2026-04-16 |
| Goodman Noah | Sale | -10,264 | $86.62 | $889,047 | 2026-04-10 |
| Goodman Noah | Derivatives Exercise | 2,500 | 2026-04-10 | ||
| Chadwick Jeremy G | Sale | -22,240 | $85.38 | $1,898,833 | 2026-04-01 |
| Chadwick Jeremy G | Derivatives Exercise | 22,240 | 2026-04-01 | ||
| Ridloff Elena | Sale | -12,000 | $85.37 | $1,024,441 | 2026-04-01 |
| Ridloff Elena | Derivatives Exercise | 12,000 | 2026-04-01 | ||
| Chadwick Jeremy G | Sale | -115,977 | $76.73 | $8,899,252 | 2026-03-25 |
| Chadwick Jeremy G | Derivatives Exercise | 109,127 | 2026-03-25 | ||
| Esposito Pamela | Sale | -2,500 | $77.71 | $194,278 | 2026-03-20 |
| Esposito Pamela | Derivatives Exercise | 2,500 | 2026-03-20 | ||
| Gollob Jared | Sale | -49,307 | $87.37 | $4,308,007 | 2025-12-08 |
| Gollob Jared | Derivatives Exercise | 49,307 | 2025-12-08 | ||
| Mainolfi Nello | Sale | -100,000 | $89.17 | $8,917,000 | 2025-12-08 |
| Mainolfi Nello | Derivatives Exercise | 100,000 | 2025-12-08 | ||
| Albers Jeffrey W. | Sale | -5,000 | $89.32 | $446,615 | 2025-12-08 |
| Albers Jeffrey W. | Derivatives Exercise | 5,000 | 2025-12-08 | ||
| Mainolfi Nello | Sale | -30,000 | $59.72 | $1,791,675 | 2025-10-29 |
| Mainolfi Nello | Derivatives Exercise | 30,000 | 2025-10-29 | ||
| Gollob Jared | Sale | -59,576 | $60.37 | $3,596,603 | 2025-10-15 |
| Gollob Jared | Derivatives Exercise | 51,209 | 2025-10-15 | ||
| Gollob Jared | Sale | -3,114 | $60 | $186,840 | 2025-10-14 |
| Gollob Jared | Derivatives Exercise | 1,473 | 2025-10-14 | ||
| Albers Jeffrey W. | Sale | -5,000 | $59.19 | $295,949 | 2025-10-14 |
| Albers Jeffrey W. | Derivatives Exercise | 5,000 | 2025-10-14 | ||
| Jacobs Bruce N. | Sale | -79,220 | $50 | $3,961,380 | 2025-09-17 |
| Jacobs Bruce N. | Derivatives Exercise | 79,220 | 2025-09-17 | ||
| Mainolfi Nello | Sale | -30,000 | $49 | $1,470,000 | 2025-09-16 |
| Mainolfi Nello | Derivatives Exercise | 30,000 | 2025-09-16 | ||
| Adams Brian | Grant, award...etc | 52,500 | 2025-09-03 | ||
| BVF PARTNERS L P/IL | Open Market Purchase | 317,167 | $44 | 2025-07-01 | |
| BAKER BROS. ADVISORS LP | Open Market Purchase | 655,500 | $44 | 2025-06-30 | |
| Ridloff Elena | Sale | -4,500 | $50 | $225,000 | 2025-06-11 |
| Ridloff Elena | Derivatives Exercise | 4,500 | 2025-06-11 | ||
| Esposito Pamela | Sale | -5,000 | $49.04 | $245,186 | 2025-06-03 |
| Esposito Pamela | Derivatives Exercise | 5,000 | 2025-06-03 | ||
| Mainolfi Nello | Sale | -30,000 | $49 | $1,470,000 | 2025-06-03 |
| Mainolfi Nello | Derivatives Exercise | 30,000 | 2025-06-03 | ||
| Ridloff Elena | Sale | -12,000 | $45.5 | $546,000 | 2025-06-03 |
| Ridloff Elena | Derivatives Exercise | 12,000 | 2025-06-03 | ||
| Albers Jeffrey W. | Sale | -6,349 | $49 | $311,101 | 2025-06-03 |
| Albers Jeffrey W. | Derivatives Exercise | 6,349 | 2025-06-03 | ||
| Chadwick Jeremy G | Sale | -2,575 | $29.3 | $75,436 | 2025-05-23 |
| Goodman Noah | Grant, award...etc | 50,000 | 2025-04-09 | ||
| Jacobs Bruce N. | Derivatives Exercise | 25,000 | 2025-04-01 | ||
| Chiniara Ellen | Sale | -2,241 | $30.33 | $67,963 | 2025-03-03 |
| Chiniara Ellen | Grant, award...etc | 27,500 | 2025-03-03 | ||
| Chadwick Jeremy G | Sale | -1,383 | $30.33 | $41,942 | 2025-03-03 |
| Chadwick Jeremy G | Grant, award...etc | 25,000 | 2025-03-03 | ||
| Jacobs Bruce N. | Sale | -7,035 | $30.33 | $213,351 | 2025-03-03 |
| Jacobs Bruce N. | Grant, award...etc | 30,000 | 2025-03-03 | ||
| Gollob Jared | Sale | -5,740 | $30.33 | $174,078 | 2025-03-03 |
| Gollob Jared | Grant, award...etc | 30,000 | 2025-03-03 | ||
| Jacobs Bruce N. | Derivatives Exercise | 10,000 | 2025-01-13 | ||
| Mainolfi Nello | Derivatives Exercise | 10,000 | 2025-01-13 | ||
| Chiniara Ellen | Sale | -3,129 | $41.75 | $130,645 | 2025-01-06 |
| Esposito Pamela | Sale | -2,500 | $49 | $122,500 | 2024-12-02 |
| Esposito Pamela | Derivatives Exercise | 2,500 | 2024-12-02 | ||
| Esposito Pamela | Sale | -13,500 | $47.75 | $644,566 | 2024-09-17 |
| Esposito Pamela | Derivatives Exercise | 13,500 | 2024-09-17 | ||
| Albers Jeffrey W. | Sale | -5,000 | $49.1 | $245,509 | 2024-08-26 |
| Albers Jeffrey W. | Derivatives Exercise | 5,000 | 2024-08-26 | ||
| BVF PARTNERS L P/IL | Open Market Purchase | 358,288 | $40.75 | 2024-08-22 | |
| BAKER BROS. ADVISORS LP | Open Market Purchase | 1 | $46.41 | 2024-08-22 | |
| Gollob Jared | Sale | -39,600 | $45.15 | $1,787,896 | 2024-07-16 |
| Gollob Jared | Derivatives Exercise | 39,600 | 2024-07-16 |
The information provided in this report about KYMR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kymera Therapeutics, Inc(NASDAQ:KYMR) 
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase...
Website: http://www.kymeratx.com
Founded: 2016
Full Time Employees: 64
CEO: Nello Mainolfi
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends